Report Overview

Global Cold Plasma Market- Industry Trends & Forecast Report 2027

The global cold plasma market was worth USD 1.9 billion in 2020 and is further projected to reach USD 5.8 billion by the year 2027, growing at the CAGR of 18.3% in the forecast period (2021-2027). The demand for cold plasma is advancing because of its expanding adoption in medical treatment with the rising incidences of Hospital-Acquired Infections (HAIs). The use of cold plasma in plasma therapy for the treatment of Covid-19 is also becoming a significant factor in the growth of the cold plasma market.

Source: BlueWeave Consulting

Global Cold Plasma Market- Overview

Cold plasma is an ionized gas in which the constituent atoms are at different temperatures. The temperature of neutral atoms is normal, whereas the temperature of electrons is higher. The cold plasma treatment is usually used for wound sterilizing and healing as it offers painless as well as contactless treatment. Cold plasma therapy is highly preferred for treating chronic wounds and burns. After being exposed to cold plasma, bacterial cells, particularly Multidrug Resistant bacteria, are instantly destroyed. Furthermore, plasma treatment is relatively cost-effective, making it accessible to a larger population. As a result, demand for this treatment is increasing rapidly, which is driving up the demand for cold plasma, particularly in the medical sector.

Global Cold Plasma Market Forecast and Trends

Growth Drivers

High Applicability of Cold Plasma in Various Industries

Cold plasma has a broad range of applications and is widely used in a variety of industries, including medicine, textiles, dyeing, printing, polymer and plastic manufacturing, and so on. They are widely utilized in the processing sector because they provide numerous benefits, including low energy and water consumption, reduced fiber degradation, reduced chemical consumption, and environmental and health benefits, among others. Furthermore, unlike other chemicals, it does not require a high-quality supply and storage, which saves the manufacturing houses a lot of money.

Treatment of Infection and Prevention from Bacteria and Virus

Cold plasma is capable of killing viruses and bacteria with high resistance, as well as preventing infectious or communicable disorders. It is also useful in eradicating antibiotic-resistant viruses and bacteria, as well as in preventing infectious or communicable disorders. Cold Plasma has emerged as a very effective method for cleaning surfaces to destroy the coronavirus while keeping the environment safe and hygienic in the wake of the Covid-19 outbreak. Furthermore, clothing nowadays is made available only after cold plasma treatment. This has a huge impact on the growth of the cold plasma market, propelling it forward.

Restraints

Huge Capital Requirement may hinder the Market

Cold plasma production and adoption are both prohibitively expensive. Installation of sophisticated equipment necessitates large investments, and vacuum pumps add to the costs. Because of the high capital requirement, potential players are hesitant to enter the market, and small businesses may be unable to expand substantially or must rely on private investment and funding. Moreover, cold plasma production processes necessitate special operating conditions. For example, vacuum equipment used in producing cold plasma needs special operating settings such as low temperatures and controlled vacuum levels.

Impact of Covid-19 on Global Cold Plasma Market

The demand for cold plasma increased so quickly after the release of Covid-19 that even manufacturers and distributors were caught off guard. According to experts, if the therapy is done at room temperature, cold plasma is particularly successful in killing the coronavirus on various surfaces. As a result, its application for the treatment of patients infected with Covid-19, as well as disinfecting the surfaces, mainly in the healthcare facilities expanded substantially, pushing the market forward. As a result, cold plasma emerged as one of the few viable choices for treating and eradicating the coronavirus.

Global Cold Plasma Market - By Application

Based on applications, the global cold plasma market is segmented into blood coagulation, wound healing, dentistry, cancer treatment, and other medical applications. Among these, the cancer treatment segment is leading the market and is likely to dominate even during the forecast period. The wound healing segment is also growing at a faster pace. Cold plasma is particularly effective in destroying bacterial cells as well as other pathogens that are resistant to antibiotics. Moreover, patients prefer prototype plasma treatment over other treatments for chronic wounds and burns because it eliminates itching and pain.

Global Cold Plasma Market - By Regime

Based on the regime, the market is divided into low-pressure cold plasma and atmospheric cold plasma. The global cold plasma market has a high demand for atmospheric cold plasma, due to which it held the largest share in the market in the year 2020. Atmospheric cold plasma has numerous applications in areas such as health, packaging, and textiles. However, it is expected that low-pressure cold plasma will lead the market to a growing CAGR over the forecast period. Its rising adoption and application in semiconductor manufacturing, as well as the electronic industry, is propelling the market growth.

Global Cold Plasma Market - Regional Insights

Geographically, the global cold plasma market is segmented into North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), and Middle-East & Africa (MEA). Among these regions, North America held the largest market share in the year 2020. This dominance is due to the high concentration of key market players in the region, along with the availability of a wide variety of FDA-approved products. Furthermore, the rising technological advancements and developments taking place in the medical sector is contributing to the growth of the cold plasma market in this region.

Competitive Landscape

The leading market players in the global cold plasma market are U.S. Medical Innovations, ADTEC Plasma Technology Co. Ltd., Ferrarini & Benelli SRL, Relyon Plasma GmbH, P2i Limited, Cinogy Technologies gMbh, Softal Corona & Plasma Gmbh, Henniker Plasma, Plasmatreat GmbH, Coating Plasma Innovation, Thierry Corporation, Enercon Industries Corporation, Europlasma NV and other prominent players. The competitive landscape of this market is very consolidated and is essentially led by giants. The companies are consistently engaging in market expansion by adopting competitive strategies like partnerships, agreements, mergers & acquisitions, etc. to expand their customer base.

Recent Developments

• In April 2021, US Medical Innovations, LLC and the Jerome Canady Research Institute for Advanced Biological and Technological Sciences, LLC announced to have achieved success in the completion of phase 1 clinical trial in the treatment of stage 4 solid tumors, using Canady Helios Cold Plasma (CHCP).

• In April 2020, Relyon Plasma, a Germany-based industrial equipment supplier launched an atmospheric plasma system, ‘piezobrush PZ3’. It is the world’s smallest plasma handheld device that offers a wide range of applications. Piezobrush PZ3 was set to hit the market from May 2020.

Scope of the Report

By Application

• Wound Healing
• Blood Coagulation
• Dentistry
• Cancer Treatment
• Other Medical Applications

By Regime

• Low-pressure Cold Plasma
• Atmospheric Cold Plasma

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Latin America (LATAM)
• Middle-East & Africa (MEA)

1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary and Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary and Secondary Sources

2.3. Breakdown of Primary Research Respondents

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Key Questionnaire asked during Primary Interviews

2.6. Key Primary Responses

2.7. Market Size Estimation

2.8. Assumption for the Study

2.9. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Cold Plasma Market – Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunity

4.1.4.   Challenges

4.2. Recent Developments / Technical Landscape

4.3. Regulatory Framework

4.4. Porter’s Five Forces Analysis

4.5. Value Chain Analysis

4.6. Strategic Outlook

5.    Global Cold Plasma Market Overview

5.1. Market Estimates & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Application

5.2.1.1. Wound Healing

5.2.1.2. Blood Coagulation

5.2.1.3. Dentistry

5.2.1.4. Cancer Treatment

5.2.1.5. Other Medical Applications

5.2.2.   By Regime

5.2.2.1. Low-pressure Cold Plasma

5.2.2.2. Atmospheric Cold Plasma

5.2.3.   By Region

5.2.3.1. North America

5.2.3.2. Europe

5.2.3.3. Asia-Pacific (APAC)

5.2.3.4. Latin America (LATAM)

5.2.3.5. Middle-East & Africa (MEA)

6.    North America Cold Plasma Market Overview

6.1. Market Size and Forecast

6.1.1.   By Value (USD Million), 2017-2027

6.2. Market Share and Forecast

6.2.1.   By Application

6.2.2.   By Regime

6.2.3.   By Country

6.2.3.1. U.S.

6.2.3.2. Canada

7.    Europe Cold Plasma Market Overview

7.1.     Market Size and Forecast

7.1.1.   By Value (USD Million), 2017-2027

7.2.     Market Share and Forecast

7.2.1.   By Application

7.2.2.   By Regime

7.2.3.   By Country

7.2.3.1.   Germany

7.2.3.2.   U.K.

7.2.3.3.   France

7.2.3.4.   Italy

7.2.3.5.   Spain

7.2.3.6.   Russia

7.2.3.7.   Netherlands

7.2.3.8.   Rest of Europe

8.    APAC Cold Plasma Market Overview

8.1.     Market Size and Forecast

8.1.1.   By Value (USD Million), 2017-2027

8.2.     Market Share and Forecast

8.2.1.   By Application

8.2.2.   By Regime

8.2.3.   By Country

8.2.3.1.   China

8.2.3.2.   India

8.2.3.3.   Japan

8.2.3.4.   South Korea

8.2.3.5.   Rest of APAC

9.    LATAM Cold Plasma Market Overview

9.1.     Market Size and Forecast

9.1.1.   By Value (USD Million), 2017-2027

9.2.     Market Share and Forecast

9.2.1.   By Application

9.2.2.   By Regime

9.2.3.   By Country

9.2.3.1.   Mexico

9.2.3.2.   Brazil

9.2.3.3.   Rest of LATAM

10. MEA Cold Plasma Market Overview

10.1.   Market Size and Forecast

10.1.1.                By Value (USD Million), 2017-2027

10.2.   Market Share and Forecast

10.2.1.                By Application

10.2.2.                By Regime

10.2.3.                By Country

10.2.3.1.              Saudi Arabia

10.2.3.2.              UAE

10.2.3.3.              South Africa

10.2.3.4.              Turkey

10.2.3.5.              Rest of Europe

11. Competitive Landscape

11.1.1.                List of Key Producers and Their Offerings

11.1.2.                Market Share / Ranking Analysis (2020)

11.1.3.                Competitive Benchmarking, By Operating Parameters

12. COVID-19 Impact

12.1.             Future Impact

12.2.             Key Developments during COVID-19

12.3.             Impact on Market

12.3.1.                Different Scenario

12.3.2.                Impact on Companies

12.4.             Regional Impact

13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

13.1.             Terraplasma Medical GmbH

13.2.             Neoplas Med GmbH

13.3.             Wacker Chemie AG

13.4.             U.S. Medical Innovations

13.5.             ADTEC Plasma Technology Co. Ltd.

13.6.             Ferrarini & Benelli SRL

13.7.             Relyon Plasma gmbh

13.8.             P2i Limited

13.9.             Cinogy Technologies gMbh

13.10.          Softal Corona & Plasma Gmbh

13.11.          Henniker Plasma

13.12.          Plasmatreat gmbh

13.13.          Apyx Medical Corporation

13.14.          Tantec a/s

13.15.          Molecular Plasma Group

13.16.          Coating Plasma Innovation

13.17.          Thierry Corporation

13.18.          Enercon Industries Corporation

13.19.          Europlasma NV

13.20.          Other prominent players

14. Key Strategic Recommendations

 * Financial information of non-listed Companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

List of Figures

Fig: Global Cold Plasma Segmentation

Fig: Global Cold Plasma Value Chain Analysis,

Fig: Company Market Share Analysis, 2020

Fig: Global Cold Plasma Size, By Value (USD Million), 2017-2027

Fig: Global Cold Plasma Share (%), By Application, By Value, 2017-2027

Fig: Global Cold Plasma Share (%), By Regime, By Value, 2017-2027

Fig: Global Cold Plasma Share (%), By Country, By Value, 2017-2027

Fig: North America Cold Plasma Size, By Value (USD Million), 2017-2027

Fig: North America Cold Plasma Share (%), By Application, By Value, 2017-2027

Fig: North America Cold Plasma Share (%), By Regime, By Value, 2017-2027

Fig: North America Cold Plasma Share (%), By Country, By Value, 2017-2027

Fig: Europe Cold Plasma Size, By Value (USD Million), 2017-2027

Fig: Europe Cold Plasma Share (%), By Application, By Value, 2017-2027

Fig: Europe Cold Plasma Share (%), By Regime, By Value, 2017-2027

Fig: Europe Cold Plasma Share (%), By Country, By Value, 2017-2027

Fig: the Asia-Pacific Cold Plasma Size, By Value (USD Million), 2017-2027

Fig: the Asia-Pacific Cold Plasma Share (%), By Application, By Value, 2017-2027

Fig: the Asia-Pacific Cold Plasma Share (%), By Regime, By Value, 2017-2027

Fig: Asia-Pacific Cold Plasma Share (%), By Country, By Value, 2017-2027

Fig: Latin America Cold Plasma Size, By Value (USD Million), 2017-2027

Fig: Latin America Cold Plasma Share (%), By Application, By Value, 2017-2027

Fig: Latin America Cold Plasma Share (%), By Regime, By Value, 2017-2027

Fig: Latin America Cold Plasma Share (%), By Country, By Value, 2017-2027

Fig: Middle East & Africa Cold Plasma Size, By Value (USD Million), 2017-2027

Fig: Middle East & Africa Cold Plasma Share (%), By Application, By Value, 2017-2027

Fig: Middle East & Africa Cold Plasma Share (%), By Regime, By Value, 2017-2027

Fig: Middle East & Africa Cold Plasma Share (%), By Region, By Value, 2017-2027

List of Tables

Table: Global Cold Plasma Size, By Application, By Value, 2017-2027

Table: Global Cold Plasma Size, By Regime, By Value (USD Million), 2017-2027

Table: Global Cold Plasma Size, By Region, By Value (USD Million), 2017-2027

Table: North America Cold Plasma Size, By Application, By Value (USD Million), 2017-2027

Table: North America Cold Plasma Size, By Regime, By Value (USD Million), 2017-2027

Table: North America Cold Plasma Size, By Country, By Value (USD Million), 2017-2027

Table: Europe Cold Plasma Size, By Application, By Value (USD Million), 2017-2027

Table: Europe Cold Plasma Size, By Regime, By Value (USD Million), 2017-2027

Table: Europe Cold Plasma Size, By Country, By Value (USD Million), 2017-2027

Table: the Asia-Pacific Cold Plasma Size, By Application, By Value (USD Million), 2017-2027

Table: the Asia-Pacific Cold Plasma Size, By Regime, By Value (USD Million), 2017-2027

Table: the Asia-Pacific Cold Plasma Size, By Country, By Value (USD Million), 2017-2027

Table: Latin America Cold Plasma Size, By Application, By Value (USD Million), 2017-2027

Table: Latin America Cold Plasma Size, By Regime, By Value (USD Million), 2017-2027

Table: Latin America Cold Plasma Size, By Country, By Value (USD Million), 2017-2027

Table: The Middle-East & Africa Cold Plasma Size, By Application, By Value (USD Million), 2017-2027

Table: The Middle-East & Africa Cold Plasma Size, By Regime, By Value (USD Million), 2017-2027

Table: The Middle-East & Africa Cold Plasma Size, By Country, By Value (USD Million), 2017-2027

Table: Terraplasma Medical GmbH Financial Analysis

Table: Terraplasma Medical GmbH Business Overview

Table: Neoplas Med GmbH Financial Analysis

Table: Neoplas Med GmbH Business Overview

Table: Wacker Chemie AG Financial Analysis

Table: Wacker Chemie AG Business Overview

Table: U.S. Medical Innovations Financial Analysis

Table: U.S. Medical Innovations Business Overview

Table: ADTEC Plasma Technology Co. Ltd. Financial Analysis

Table: ADTEC Plasma Technology Co. Ltd. Business Overview

Table: Ferrarini & Benelli SRL Financial Analysis

Table: Ferrarini & Benelli SRL Business Overview

Table: Relyon Plasma GmbH Financial Analysis

Table: Relyon Plasma GmbH Business Overview

Table: P2i Limited Financial Analysis

Table: P2i Limited Business Overview

Table: Cinogy Technologies GmbH Financial Analysis

Table: Cinogy Technologies GmbH Business Overview

Table: Softal Corona & Plasma GmbH Financial Analysis

Table: Softal Corona & Plasma GmbH Business Overview

Table: Henniker Plasma Financial Analysis

Table: Henniker Plasma Financial Analysis

Table: Plasmatreat GmbH Financial Analysis

Table: Plasmatreat GmbH Business Overview

Table: Apyx Medical Corporation Financial Analysis

Table: Apyx Medical Corporation Business Overview

Table: Tantec a/s Financial Analysis

Table: Tantec a/s Business Overview

Table: Molecular Plasma Group Financial Analysis

Table: Molecular Plasma Group Business Overview

Table: Coating Plasma Innovation Financial Analysis

Table: Coating Plasma Innovation Business Overview

Table: Thierry Corporation Financial Analysis

Table: Thierry Corporation Business Overview

Table: Enercon Industries Corporation Financial Analysis

Table: Enercon Industries Corporation Business Overview

Table: Europlasma NV Financial Analysis

Table: Europlasma NV Business Overview